Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-23

Clinical Trial Update: Pilot Study of Fenofibrate for PSC [Phase 1, Phase 2]

View source ↗

Summary

Pilot study investigating fenofibrate for primary sclerosing cholangitis (phases 1 and 2) was terminated; results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENOFIBRATE (Fenofibrate)

Snippet

Sponsor: University of Miami | Conditions: Primary Sclerosing Cholangitis | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2013-04-23